Do We Really Need Another Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in First-Line Treatment for Patients With Non-Small-Cell Lung Cancer and EGFR Mutations?

作者:Haspinger Eva R*; Garassino Marina Chiara; Torri Valter; Cinquini Michela; De Braud Filippo; Gelsomino Francesco
来源:Journal of Clinical Oncology, 2014, 32(8): 859-863.
DOI:10.1200/JCO.2013.52.8794
  • 出版日期2014-3-10